Produkty 1422954-11-7

CAS 1422954-11-7 występuje w naszej ofercie pod nazwami: Rosuvastatin Impurity 106, Rosuvastatin Impurity 57 ((3R,5R)-Rosuvastatin Lactone), Rosuvastatin Impurity 60, (3R,5R)-Rosuvastatin lactone. Oferty producentów: Chemat Brand, Hubei YoungXin, Biosynth, MedChemExpress. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 0,5mg, 1mg.

Rosuvastatin Impurity 106
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Rosuvastatin Impurity 57 ((3R,5R)-Rosuvastatin Lactone)
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Rosuvastatin Impurity 60
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
(3R,5R)-Rosuvastatin lactone
Biosynth, MedChemExpress
  • opakowanie: 0,5mg, 1mg, 2mg, 5mg
  • Warianty: 5
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

N-[4-(4-fluorophenyl)-5-[(E)-2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide (CAS 1422954-11-7) to związek chemiczny o wzorze sumarycznym C22H26FN3O5S i masie molowej 463.5 g/mol. Nazwa systematyczna IUPAC: N-[4-(4-fluorophenyl)-5-[(E)-2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide. InChIKey: SOEGVMSNJOCVHT-ZUQFGZKASA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H26FN3O5S
Masa molowa463.5 g/mol
Nazwa IUPACN-[4-(4-fluorophenyl)-5-[(E)-2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide
InChIKeySOEGVMSNJOCVHT-ZUQFGZKASA-N
SMILESCC(C)C1=NC(=NC(=C1/C=C/[C@H]2C[C@H](CC(=O)O2)O)C3=CC=C(C=C3)F)N(C)S(=O)(=O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: (3R,5R)-Rosuvastatin Lactone, Rosuvastatin Impurity 57, Rosuvastatin (3R,5R)-Lactone, orb1706296, Rosuvastatin Impurity 57 ((3R,5R)-Rosuvastatin Lactone)
Powiązane formy tego związku
N-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide C22H26FN3O5S
Izomery (ten sam wzór sumaryczny)
N-[(6R)-8-fluoro-6-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]-4-propan-2-yl-5,6-dihydrobenzo[h]quinazolin-2-yl]-N-methylmethanesulfonamide C22H26FN3O5S
(2Z,5R,6E)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-5-hydroxyhepta-2,6-dienoic acid C22H26FN3O5S
(2E,5S,6E)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-5-hydroxyhepta-2,6-dienoic acid C22H26FN3O5S
(3S,4E,6E)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3-hydroxyhepta-4,6-dienoic acid C22H26FN3O5S
(2Z,5S,6E)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-5-hydroxyhepta-2,6-dienoic acid C22H26FN3O5S
N-[(6S)-8-fluoro-6-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]-4-propan-2-yl-5,6-dihydrobenzo[h]quinazolin-2-yl]-N-methylmethanesulfonamide C22H26FN3O5S